Science

Wellness startup co-founder on music as a primary modality to treat mental health issues (podcast episode)

In 2011, Aaron Labbé was diagnosed with Bi-polar 1 Disorder, after over a year of un-diagnosed mania and psychosis that caused a number of lasting scars in his life.

In February 2012, he was forcibly hospitalized for the first time and kicked out of the music conservatory he was studying at. His life has never been the same since. 

That hospital experience itself was traumatizing, as he had a doctor tell him to cope with the fact that he couldn’t finish school, wouldn’t be able to keep a professional job, and should ultimately settle into a more passive lifestyle.

Before this experience, his dream was to be a professional musician – but at that point, he decided to dedicate his life to creating a more empathetic mental health system. As a result, Labbé co-founded LUCID, a startup with a mission to turn music into medicine. 

He now works as the team’s CTO and has spent the last 4 years working tirelessly to turn music into a validated medicine for mental health.

Listen to this podcast on SpotifyAnchorApple PodcastsBreakerGoogle PodcastsStitcherOvercastListen NotesPodBean, and Radio Public.

In today’s episode, we sit down with Labbé to discuss some of the research they are working on, what it entails and what it has demonstrated so far. 

We also explore how psychedelics play a role in the work LUCID does. Alongside, the legal implications of working in the psychedelic space as a startup in Canada. And finally, Labbé shares what is next for the therapeutic music startup. 

The Sociable

Recent Posts

WEF promotes eat the bugs agenda in ‘new nature economy’ report

The push to eat bugs is not an organic movement coming from the people, but…

18 hours ago

Africa’s Digital Assets Push Gets an Upgrade as ADAS Teams-Up With CEO’s Forum

As Africa’s digital economy accelerates, a new partnership between the Africa Digital Assets Summit 2026…

1 day ago

Why companies can’t afford black-box AI anymore

The State of Generative AI in the Enterprise report from Menlo Ventures found that companies…

1 day ago

From one donor, thousands of doses: Meet the startup making cell therapy accessible

Living therapies, made of engineered immune cells – and capable of hunting down cancer, reversing…

2 days ago

World Models: The architectural bet behind AI’s next frontier

Yann LeCun's AMI Labs just raised $1.03 billion to build AI that understands reality, not…

3 days ago